[Iodine myxedema during amiodarone treatment]. 1971

P Guinet, and G Pousset, and J Briere, and G G Bianchi

UI MeSH Term Description Entries
D007455 Iodine A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically. Iodine-127,Iodine 127
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009230 Myxedema A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips. Myxedemas
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran

Related Publications

P Guinet, and G Pousset, and J Briere, and G G Bianchi
March 1986, The Journal of clinical endocrinology and metabolism,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
January 1972, Pediatrie,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
October 1984, The American journal of medicine,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
October 2020, The American journal of case reports,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
August 2020, Cureus,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
February 1974, Nihon Naibunpi Gakkai zasshi,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
September 1966, Nordisk medicin,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
February 1997, Journal of hepatology,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
July 1957, Lyon medical,
P Guinet, and G Pousset, and J Briere, and G G Bianchi
April 1958, Harefuah,
Copied contents to your clipboard!